NPPA and breast adenocarcinoma: Vessel dilator, LANP, kaliuretic peptide and ANP eliminate 67%, 50%, 67% and 33% of the human breast adenocarcinomas in athymic mice when infused subcutaneously for 28 days with weekly fresh hormones at 3 nM min-1 kg-1 body weight [41].